Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

160 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Real-time polymerase chain reaction and intraocular antibody production for the diagnosis of viral versus toxoplasmic infectious posterior uveitis.
Errera MH, Goldschmidt P, Batellier L, Degorge S, Héron E, Laroche L, Sahel JA, Westcott M, Chaumeil C. Errera MH, et al. Among authors: heron e. Graefes Arch Clin Exp Ophthalmol. 2011 Dec;249(12):1837-46. doi: 10.1007/s00417-011-1724-7. Epub 2011 Jul 6. Graefes Arch Clin Exp Ophthalmol. 2011. PMID: 21732111
Prognostic Factors in Syphilitic Uveitis.
Hoogewoud F, Frumholtz L, Loubet P, Charlier C, Blanche P, Lebeaux D, Benhaddou N, Sedira N, Coutte L, Vanhaecke C, Launay O, Le Jeunne C, Héron E, Monnet D, Lortholary O, Sahel JA, Dupin N, Brézin A, Errera MH, Salah S, Groh M. Hoogewoud F, et al. Among authors: heron e. Ophthalmology. 2017 Dec;124(12):1808-1816. doi: 10.1016/j.ophtha.2017.06.003. Epub 2017 Aug 2. Ophthalmology. 2017. PMID: 28779905
A Comparison of the Dexamethasone Implant (Ozurdex®) and Inferior Fornix-Based Sub-Tenon Triamcinolone Acetonide for Treatment of Inflammatory Ocular Diseases.
Errera MH, Westcott M, Benesty J, Falah S, Smadja J, Orès R, Pratas AC, Sedira N, Bensemlali A, Héron E, Goldschmidt P, Bodaghi B, Sahel JA. Errera MH, et al. Among authors: heron e. Ocul Immunol Inflamm. 2019;27(2):319-329. doi: 10.1080/09273948.2018.1501492. Epub 2018 Aug 6. Ocul Immunol Inflamm. 2019. PMID: 30081675
Review of the Current Literature and Our Experience on the Value of OCT-angiography in White Dot Syndromes.
Mebsout-Pallado C, Orès R, Terrada C, Dansingani KK, Chhablani J, Eller AW, Martel JN, Anetakis A, Harwick JC, Waxman EL, Gallagher DS, Prensky C, Indermill C, Sedira N, Héron E, Paques M, Brignole-Baudouin F, Bodaghi B, Sahel JA, Gaudric A, Mrejen S, Errera MH. Mebsout-Pallado C, et al. Among authors: heron e. Ocul Immunol Inflamm. 2022 Feb 17;30(2):364-378. doi: 10.1080/09273948.2020.1837185. Epub 2021 Feb 22. Ocul Immunol Inflamm. 2022. PMID: 33617412 Review.
Cytokines, chemokines and growth factors profile in human aqueous humor in idiopathic uveitis.
Errera MH, Pratas A, Fisson S, Manicom T, Boubaya M, Sedira N, Héron E, Merabet L, Kobal A, Levy V, Warnet JM, Chaumeil C, Brignole-Baudouin F, Sahel JA, Goldschmidt P, Bodaghi B, Bloch-Queyrat C. Errera MH, et al. Among authors: heron e. PLoS One. 2022 Jan 21;17(1):e0254972. doi: 10.1371/journal.pone.0254972. eCollection 2022. PLoS One. 2022. PMID: 35061677 Free PMC article.
Late posterior segment relapses in a series of Vogt-Koyanagi-Harada disease.
Errera MH, Levinson RD, Fardeau C, Thomas D, Cohen D, Navarro A, Héron E, Paques M, Pavesio C, Sahel JA, Westcott MC, Gaudric A, LeHoang P, Bodaghi B. Errera MH, et al. Among authors: heron e. Acta Ophthalmol. 2015 Sep;93(6):e509-10. doi: 10.1111/aos.12640. Epub 2015 Jan 21. Acta Ophthalmol. 2015. PMID: 25604241 Free article. No abstract available.
Ocular tuberculosis: experience of an Italian and French cohort.
Mora P, Ghirardini S, Héron E, Sedira N, Olcelli F, Gandolfi S, Sahel JA, Errera MH. Mora P, et al. Among authors: heron e. Acta Ophthalmol. 2015 Aug;93(5):e403-e404. doi: 10.1111/aos.12602. Epub 2014 Dec 9. Acta Ophthalmol. 2015. PMID: 25488026 Free article. No abstract available.
Tocilizumab versus Rituximab in Patients with Moderate to Severe Steroid-resistant Graves' Orbitopathy.
Bennedjaï A, Bouheraoua N, Gatfossé M, Dupasquier-Fediaevsky L, Errera MH, Tazartes M, Borderie V, Hennocq Q, Dellal A, Riviere S, Heron E, Fain O, Mekinian A. Bennedjaï A, et al. Among authors: heron e. Ocul Immunol Inflamm. 2022 Feb 17;30(2):500-505. doi: 10.1080/09273948.2020.1808688. Epub 2020 Sep 23. Ocul Immunol Inflamm. 2022. PMID: 32965148
160 results